Articles related to ALZHEIMER'S/DEMENTIA

This recent study reveals that addressing modifiable risk factors like education level and mental health could play a crucial role in preventing young-onset dementia, offering a new perspective in dementia care.

In a significant shift, recent findings indicate that statins, specifically simvastatin, may play a crucial role in enhancing cognitive function in dementia patients, challenging the traditional perception of their use.

The study reveals a significant correlation between food insecurity and increased dementia risk, with odds ratios of 1.38 and 1.37 for low and very low food security, respectively.

The therapy aims to restore progranulin protein levels in the brain, marking a significant step forward in the treatment of neurodegenerative disorders.

A recent study found a 69 percent increased risk of Alzheimer’s diagnosis within a year of COVID-19 infection in individuals aged 65 years and older. This significant link between viral infections and Alzheimer’s disease could have major implications for our understanding of neurodegenerative diseases and their treatment.

Leqembi, a newly FDA-approved drug, has shown promising results in clinical trials, resulting in a 28% slower decline in Alzheimer’s patients compared to placebo. This equates to an additional four to five months of retained function.